Qatar’s health ministry recalls seven medicines over fears of potential cancer risks
The Ministry of Public Health has recalled seven pharmaceutical products that contain the ingredient Valsartan, manufactured by Chinese company Zhejiang Huahai Pharmaceutical LT, on the suspicion of them having carcinogenic properties, reported Gulf Times.
Ministry of Public Health recalled seven pharmaceutical products that contain ingredient valsartan on the suspicion of containing a carcinogenic flaw. pic.twitter.com/Fuqx9ld3u2
The Pharmacy and Drug Control department at the ministry said it received memos from international organisations on the possibility of a ‘carcinogenic flaw’ called n-nitrosodimethylamine (NDMA) in the active substance Valsartan manufactured by the company.
The ministry said it withdrew all the pharmaceutical products that contain the active substance, once it received the memo, according to The Peninsula.
The list of recalled products includes Cinfaval and Co-cinfaval manufactured by Spanish Cinfa Laboratories, as well as Diostar and Diostar plus manufactured by Jordan's Pharma International Co.
In addition to Anginet and Co-Anginet produced by the Jordanian United Pharmaceuticals Manufacturing Co and Valzaar manufactured by the Indian Torrent Pharmaceuticals.
The ministry revealed that products that contain the active substance Valsartan manufactured by other companies are safe and are not included in the withdrawal process, reported Qatar Tribune.
The Pharmacy and Drug Control Department said it was in continuous contact with the World Health Organisation, institutions and other health organisations for medicines and pharmaceuticals.
So diovan 80 (valsartan),from Spain manufactured .we can use it.